Lymph node neoplasm

Summary

Lymph node neoplasm (MONDO:0024339) is a cancer and 2 clinical trials. A subtype of hematopoietic and lymphoid system neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	lymph node neoplasm
Mondo ID	MONDO:0024339
NCIT	C35497
UMLS	C0596869
MedGen	108920
GARD	0006932
Anatomy (UBERON)	UBERON:0000029
Is cancer (heuristic)	yes

Also known as: lymph node neoplasm · lymph node neoplasm (disease) · lymph node tumor · lymph node tumour · neoplasm of lymph node · tumor of lymph node · tumour of lymph node

Disease family

This is a subtype of hematopoietic and lymphoid system neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › hematopoietic and lymphoid system neoplasm › lymph node neoplasm

Related subtypes (8): cavernous hemangioma, thymus neoplasm, bone marrow neoplasm, STAT3-related early-onset multisystem autoimmune disease, myeloid hemopathy, lymphoid hemopathy, spleen neoplasm, hematopoietic and lymphoid cell neoplasm

Subtypes (3): lymph node cancer, lymph node palisaded myofibroblastoma, benign neoplasm of lymph node

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06527027	Not specified	RECRUITING	LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes
NCT00165100	Not specified	COMPLETED	Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer